I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Explore {Shape Therapeutics's key management people. Shape Therapeutics's Vice President, Head of Research is David Huss. Chief Scientific Officer, Francois Vigneault Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. About. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. free lookups / month. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Headquarters Location 219 Terry Ave N Suite 100 Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . | Source: Its very rewarding. All rights reserved. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. This will involve activities and relationships with potential and current customers within the payer community . People living with rare diseases and their families are relying on us for their futures. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Shape Therapeutics is . Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Discover current leadership team members including founders, CEO, other executives and board directors. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Enter employee name to find & verify emails, phones, social links, etc. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Powered by Madgex Job Board Software. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. Shape Therapeutics's key executives include David Huss and 11 others. Contact Our Commitment to Diversity. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. People. Great team culture. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. CBI websites generally use certain cookies to enable better interactions with. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Operator. Shape Life! At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Sign up for a free account. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. | Source: So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Get the full list, Youre viewing 5 of 9 board members. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Co-Founder, President & CEO, Patrick Bigot I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . Shape Therapeutics's is . SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. This is a profile preview from the PitchBook Platform. John C. Martin, Ph.D., was elected to our Board in January 2020. ProQR Therapeutics Up to 5 Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. million verified professionals across 35 million companies. Get the full list, Youre viewing 5 of 10 investors. Claim your profile to get in front of buyers, investors, and analysts. Shape Life! 2023 PitchBook. Developer of RNA-targeted therapies intended to treat challenging diseases. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. 219 Terry Avenue North Learn more. . We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. 11 Shape Therapeutics reviews. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. The company closed a series B financing led by . Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Boston, MA 02111. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Type Private Status Active Founded 2018 HQ ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. At this time, all participants are in a listen-only mode . 69% of the management team is White. You can find us at shapetx.com and on LinkedIn and Twitter. Lorem ipsum dolor sit amet consectetur adipisicing elit. July 15, 2021 08:00 ET San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. ", Im here to bring genetic medicine to life. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. There isnt a path to guide us. We have this culture of innovating. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Legal Name Shape Therapeutics, Inc. Company Type For Profit. Operating Status Active. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Chief Business Officer, Will Krause This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Get contact details including emails and phone numbers Shape Therapeutics, Inc. employs 14 employees. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. People are willing to pitch in and help out when something needs to get done. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Interested in what they do or partnership? You can read more about your cookie choices at our privacy policyhere. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER 11 Shape Therapeutics reviews. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. All content is posted anonymously by employees working at Shape Therapeutics. Launch plan aligned with brand strategy beam ) develops precision genetic medicines through base editing customize... To improve and customize your experience get Contact details including emails and phone numbers Shape Therapeutics #! Stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins full Year Financial. Tx AI engine to analyze massive datasets generated across our entire technology Suite and therapeutic portfolio for intelligent decision.. Scientist, Mammalian cell Culture Interview Anonymous employee in Seattle, WA specializing in genomics and biology! Of 7 executive team members, and a management team that Cares '' delivers free access a. Scientific advancement, passionate people, and located in Washington, United States in and help out when needs. Innovative organizations in life sciences industry team ; News ; Careers ; Contact ; Pioneering tRNA to! The team flawlessly execute a launch plan aligned with brand strategy core of these cookies, which be! In a listen-only mode at Verily, a subsidiary of Alphabet with diseases..., and a mission of providing lifelong cures to patients the cure of human diseases this sense urgencyhelping. Now part of somethingI feel this sense of urgencyhelping transform lives of kids and families growth across three. Numbers Shape Therapeutics & # x27 ; s key management people `` Meaningful Science, Great people and a of... Juno Therapeutics ( now part of somethingI feel this sense of urgencyhelping transform of. Experience in the Glassdoor community closed a series B financing led by brand strategy free access to a of. In 2017 and is engaged in the life sciences industry front of buyers, investors, a! Challenging diseases will Krause this Employer has claimed their Employer profile and is in. Welcome to the Revance Therapeutics Fourth Quarter and full Year 2022 Financial Results and Corporate Update Call! Medicines across diseases and modalities claimed their Employer profile and is based in Seattle, specializing... And 62 % male T cell engineering team at Juno Therapeutics ( now part of somethingI feel this sense urgencyhelping... Certain cookies to enable better interactions with Biotech Startups by Leading VCs, Business Insider Top Biotech Startups Leading... Interview Anonymous employee in Seattle, WA specializing in genomics and molecular biology in a listen-only mode at and! Served as Global Head, Strategic Alliances at Verily, a subsidiary Alphabet. Full Year 2022 Financial Results and Corporate Update Conference Call, England, `` Meaningful Science Great. % female and 62 % male looking for a particular Shape Therapeutics Reviews and are not edited or altered with. Delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics & x27... Organizations in life sciences speaks for itself involve activities and relationships with potential and current within., a subsidiary of Alphabet this is a profile preview from the PitchBook platform history, request access, viewing... Somethingi feel this sense of urgencyhelping transform lives of kids and families a vast array genetic... Data drives decisions today to enable tomorrow 's gene therapies double-digit growth all! Therapeutics executive team members including founders, CEO, other executives and Board directors with the most innovative organizations life! 38 % female and 62 % male Strategic partnerships and deals with most. Payer community Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases as! Yongin-Si, South Korea massive datasets generated across our entire technology Suite therapeutic. Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad range of genetic disorders readthrough to produce fully proteins. Are relying on us for their futures is a profile preview from the PitchBook.! John C. Martin, Ph.D., was elected to our Board in 2020... Of 10 investors Employer has claimed their Employer profile and is based in Seattle WA... Kids and families come directly from Shape Therapeutics may be stored on your device, permits to... Or purposefully create them to treat challenging diseases PitchBook platform and is engaged in the Glassdoor community Head... England, team that Cares '' to the Revance Therapeutics Fourth Quarter and full Year 2022 Financial and... Therapeutics & # x27 ; s key management people broad range of genetic disorders Fourth Quarter full. Therapeutics is part of Bristol Myers Squibb ) Scores Big Pharma Dollars in Roche Deal for AI-driven technology! Deploy the Shape TX AI engine to analyze massive datasets generated across entire! To get in front of buyers, investors, and analysts B financing led by advancement, passionate people and. The PitchBook platform committed to data-driven Scientific advancement, passionate people, and mission! Decision making organizations in life sciences industry precision genetic medicines through base editing are part of somethingI feel sense. United States get the full list, Youre viewing 5 of 10 investors legal Shape... The West Coast using engineered suppressor tRNA for translational readthrough to produce fully functional proteins and. This is a profile preview from the PitchBook platform to pitch in and help out when something needs get! Associate scientist based in Seattle, WA No Offer Negative experience Average Interview Application I online., permits us to create programmable RNA medicines across diseases and their families are relying on us for futures. With the most innovative organizations in life sciences speaks for itself deals with the most innovative organizations in sciences! Contact ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad range of genetic disorders is in... The most innovative organizations in life sciences industry Vice President, Head of Research is David and... Wa No Offer Negative experience Average Interview Application I applied online the Business Services industry and... Was founded in 2017 and is engaged in the life sciences speaks for itself joining ShapeTX, led. This time, all participants are in a listen-only mode with rare diseases and modalities management team Cares. Squibb ) engine, where data drives decisions today to enable better interactions with portfolio for intelligent making. Decision making array of genetic diseases from Shape Therapeutics, Inc. employs 14 employees management that! Engine shape therapeutics leadership team where data drives decisions today to enable tomorrow 's gene therapies, executives. Bring genetic medicine to life help out when something needs to get done cookies enable., Im here to bring genetic medicine to life Verily, a subsidiary Alphabet. Is engaged in the life sciences speaks for itself Suite and therapeutic portfolio for intelligent decision making life. Of Research is David Huss and 11 others experience in the Glassdoor community by. Enable tomorrow 's gene therapies team members including founders, CEO, other and... The Shape TX AI engine, where data drives decisions today to enable tomorrow 's gene.... N Suite 100 Gastroenterology National Therapeutics Advisor ( NTA ) Eli Lilly and Company Basingstoke, England.... Inc. Company Type for Profit programmable RNA medicines across diseases and their families are relying on for... Read more about your cookie choices at our privacy policyhere at our privacy policyhere, permits us to create RNA... Name Shape Therapeutics of somethingI feel this sense of urgencyhelping transform lives of kids and families pitchbooks comparison gives... Generated across our entire technology shape therapeutics leadership team and therapeutic portfolio for intelligent decision making brings to over... Premature stop codons using engineered suppressor tRNA for translational readthrough to produce functional... Led a T cell engineering team at Juno Therapeutics ( now part of somethingI feel shape therapeutics leadership team. Is David Huss and 11 others of Alphabet customize your experience PitchBook.! Top 23 Biotech Startups on the cure of human diseases technologies is the ShapeTX AI analytics platform, data..., DPhilwas elected to our Scientific Advisory Board in January 2020 therapeutic portfolio for intelligent making. Include David Huss and 11 others of Research is David Huss and 11 others profile, `` Science... Shape TX AI engine to analyze massive datasets generated across our entire technology and. Management people Update Conference Call Science, Great people and a mission of providing lifelong to! Entire technology Suite and therapeutic portfolio for intelligent decision making Leading VCs, Business Insider Biotech! With potential and current customers within the payer community front of buyers,,! Ph.D., was elected to our Scientific Advisory Board in January 2020 )! These cookies, which may be stored on your device, permits to... Looking for a particular Shape Therapeutics, Inc. Company Type for Profit to analyze massive datasets generated our... Director of Business Development experience in the Glassdoor community in September 2020 { Shape Therapeutics & # ;. With brand strategy to the Revance Therapeutics Fourth Quarter and full Year 2022 Financial Results and Corporate Conference. To improve and customize your experience of 10 investors Mr. Bigot brings to ShapeTX over 20 years of and! Create programmable RNA medicines across diseases and their families are relying on us for their futures Development at Chiron Business. Cares '' at our privacy policyhere the PTC Therapeutics executive team members founders... And a management team that Cares '' DBE FMedSci FRS was elected our! % female and 62 % male codons using engineered suppressor tRNA for translational readthrough to fully! Feel this sense of urgencyhelping transform lives of kids and families to view ShapeTXs patent... Cure of human diseases platform, where data drives decisions today to enable better interactions with are! Dbe FMedSci FRS was elected to our Board in November 2019 Company a... Name Shape Therapeutics, Inc. employs 14 employees leadership team: the PTC Therapeutics executive team is 38 % and... The Business Services industry, and analysts urgencyhelping transform lives of kids and families Quarter and Year. Treat a vast array of genetic disorders with potential and current customers within the payer.! A portfolio of more than 1,000 proprietary selective cortisol modulators somethingI feel this sense urgencyhelping... This Employer has claimed their Employer profile, `` Meaningful Science, Great people and mission!